Efficacy and Safety of Two Doses of Hipnos in the Treatment of Adults With Insomnia

Status:
Withdrawn

Trial end date:
2022-03-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy and safety of three doses of Hipnos medication in adults with insomnia.

Phase 2

EMS